Zhejiang Jingxin Pharmaceutical Co., Ltd.
符号: 002020.SZ
SHZ
12.29
CNY今天的市场价格
16.3059
市盈率
-1.6917
PEG比率
10.58B
MRK市值
- 0.02%
DIV收益率
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020-SZ) 财务报表
资产负债表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 7335.53 | 2019.9 | 1915.4 | 1977.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1127.56 | 609.3 | 366.9 | 422.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 2431.47 | 664 | 570 | 586.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 2703.54 | 652.7 | 773.7 | 649.1 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 299.73 | 17.1 | 22.1 | 16.5 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 12770.27 | 3353.7 | 3281.2 | 3229.5 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8656.05 | 2309.8 | 1632.1 | 1262.9 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 1393.94 | 348.5 | 348.5 | 257.9 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1617.31 | 401.3 | 418.6 | 137.7 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3011.25 | 749.7 | 767.1 | 395.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2754.28 | 1471.1 | 218.9 | 119.5 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 297.88 | 81 | 75.1 | 62.5 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 4007.56 | 21.2 | 1388.1 | 1345.3 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 18727.02 | 4632.8 | 4081.4 | 3185.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 3316.2 | 610.8 | 719.1 | 435.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 1704.65 | 621.3 | 253.3 | 161.9 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 199.19 | 44.3 | 105.4 | 95 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 139.56 | 31.2 | 43 | 6.6 | |||||||||||||||||||||||
Deferred Revenue Non Current | 1091.72 | 268.8 | 270.6 | 128.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 254.92 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 805.52 | 789.3 | 761.9 | 4.7 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1227.33 | 102.8 | 375.2 | 192.6 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 139.56 | 31.2 | 43 | 6.5 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 9357.68 | 2177.6 | 2190.6 | 1577.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 3444.12 | 861 | 861 | 905.3 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9981.01 | 2540.1 | 2228.8 | 1871.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4893.06 | 388 | 336.1 | 285.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3443.45 | 1723.3 | 1720.2 | 1755.1 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 21761.63 | 5512.4 | 5146.1 | 4817.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 109.17 | 27.8 | 25.8 | 20.2 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 21870.8 | 5540.2 | 5172 | 4837.7 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 31497.29 | - | - | - | |||||||||||||||||||||||
Total Investments | 3881.85 | 2080.4 | 585.8 | 541.9 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 1844.21 | 652.5 | 296.3 | 168.5 | |||||||||||||||||||||||
balance-sheet.row.net-debt | -4363.76 | -758.2 | -1252.2 | -1386.3 |
现金流量表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 638.91 | 618.9 | 667.8 | 614.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 10.99 | 221.5 | 166.9 | 143.6 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.8 | -12.2 | -5.8 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -488 | 12.2 | 5.8 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 29.56 | -45 | 21.3 | -391.7 | ||||||||||||||||||||||
cash-flows.row.account-receivables | -93.48 | -93.5 | -250.9 | -208.6 | ||||||||||||||||||||||
cash-flows.row.inventory | 123.04 | 123 | -103 | -147.8 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -74.6 | 387.4 | -41.8 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -12.2 | 6.5 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 275.34 | 514.5 | -0.3 | -1.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 954.8 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 9.85 | 10.3 | 5.2 | 8.3 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -870.2 | -1175.2 | -1058 | -861.7 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1011.18 | 915 | 833.9 | 1407.9 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 311.97 | 0 | -3.2 | -5.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -189.34 | -769.4 | -737.7 | 144.7 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | -339.22 | -35 | -150 | -300.3 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | -258.11 | -258.3 | -258.6 | -232.2 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 593.64 | -4 | 220.5 | 653.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -180.91 | -245.6 | -188 | 120.8 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5.78 | 2.7 | 14.9 | -3.8 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 684.27 | -77.8 | -55 | 626.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 5962.04 | 1410.6 | 1463.7 | 1512.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 5277.77 | 1488.5 | 1518.7 | 886 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 954.8 | 824.7 | 855.8 | 365 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 615.02 | 305.2 | 340.2 | -39.4 |
利润表行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4082.46 | 3952.1 | 3779.8 | 3336 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2026.66 | 2048.3 | 1766.1 | 1472.8 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 2055.8 | 1903.8 | 2013.7 | 1863.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 410.79 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 78.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1442.43 | 1324.6 | 1354.4 | 1250.3 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3469.09 | 3372.9 | 3120.5 | 2723 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 43.91 | 60.3 | 65.6 | 48.1 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 82.38 | 221.5 | 182.9 | 170.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 740.39 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 658.01 | 579.2 | 756.6 | 693 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 735.28 | 714.1 | 750.3 | 694.5 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 90.4 | 84.6 | 82.5 | 79.8 | |||||||||||||||||||||||
income-statement-row.row.net-income | 638.91 | 618.9 | 662.3 | 612.5 |
常见问题
什么是 Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) 总资产是多少?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) 总资产为 7986556907.000.
什么是企业年收入?
年收入为 2117348157.000.
企业利润率是多少?
公司利润率为 0.504.
什么是公司自由现金流?
自由现金流为 0.718.
什么是企业净利润率?
净利润率为 0.157.
企业总收入是多少?
总收入为 0.161.
什么是 Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) 净利润?{{符号}}净利润(净收入)是多少?
净利润(净收入)为 618898033.000.
公司总债务是多少?
债务总额为 652489982.000.
营业费用是多少?
运营支出为 1324586158.000.
公司现金是多少?
企业现金为 2069633166.000.